Location History:
- Kaisei-machi, JP (2003 - 2006)
- Kanagawa-ken, JP (1997 - 2009)
- Kanagawa, JP (1989 - 2010)
- Ashigarakami-gun, JP (2010 - 2016)
Company Filing History:
Years Active: 1989-2016
Areas of Expertise:
Title: Nobuhiko Ogura: Innovator in Radiographic Imaging and Oncology
Introduction
Nobuhiko Ogura is a prominent inventor based in Kanagawa, Japan. With a remarkable portfolio of 41 patents, Ogura has made significant contributions to the fields of medical imaging and cancer research. His innovations focus on enhancing radiographic imaging techniques and improving methods for analyzing gene expressions in lung cancer tissues.
Latest Patents
Among Ogura's latest patents is a radiographic image reading device that includes a reading unit designed to photoelectrically read photostimulated luminescence light. This technology utilizes a storage phosphor sheet illuminated with excitation light to capture radiographic images effectively. The device features a control unit capable of differentiating reading speeds and intensities based on the desired resolution.
Additionally, Ogura developed a method of classifying gene expression strength in lung cancer tissues. This ground-breaking invention aids in determining the five-year survival rate of lung cancer patients by confirming gene expression levels through a specialized DNA probe kit.
Career Highlights
Nobuhiko Ogura has worked with renowned organizations such as Fuji Photo Film Company, Limited and Fujifilm Corporation, contributing to advancements in imaging technologies throughout his career. His expertise and innovation have established him as a leader in his field, especially in the integration of technology and healthcare.
Collaborations
Ogura has collaborated with several notable professionals, including Hitoshi Shimizu and Katsuaki Muraishi, highlighting his ability to work effectively within teams to achieve significant advancements in his areas of expertise.
Conclusion
Nobuhiko Ogura's contributions to radiographic imaging and cancer research demonstrate the importance of innovation in improving medical outcomes. His patents reflect a commitment to enhancing diagnostic techniques and understanding gene expressions, ultimately benefiting healthcare professionals and patients alike.